北京地区肠道清洁欠佳风险评分模型的建立与验证

注册号:

Registration number:

ChiCTR2000040817 

最近更新日期:

Date of Last Refreshed on:

2021-03-31 01:09:17 

注册时间:

Date of Registration:

2020-12-11 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

北京地区肠道清洁欠佳风险评分模型的建立与验证

Public title:

Establishment and validation of risk assessment model for poor bowel cleansing in Beijing

注册题目简写:

English Acronym:

研究课题的正式科学名称:

北京地区肠道清洁欠佳风险评分模型的建立与验证

Scientific title:

Establishment and validation of risk assessment model for poor bowel cleansing in Beijing

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

徐佳宁 

研究负责人:

周巧直 

Applicant:

Xu Jianing 

Study leader:

Zhou Qiaozhi 

申请注册联系人电话:

Applicant telephone:

+86 13161598230

研究负责人电话:

Study leader's
telephone:

+86 13681403519

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1140551370@qq.com

研究负责人电子邮件:

Study leader's E-mail:

zhouqzh@sina.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京西城区永安路95号

研究负责人通讯地址:

北京西城区永安路95号

Applicant address:

95 Yongan Road, Xicheng District, Beijing

Study leader's address:

95 Yongan Road, Xicheng District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

首都医科大学附属北京友谊医院

Applicant's institution:

Beijing Friendship Hospital, Capital Medical University

研究负责人所在单位:

首都医科大学附属北京友谊医院

Affiliation of the Leader:

Beijing Friendship Hospital, Capital Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2017-P2-149-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

首都医科大学附属北京友谊医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Beijing Friendship Hospital, Capital Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2017-10-31 00:00:00

伦理委员会联系人:

崔焱

Contact Name of the ethic committee:

Cui Yan

伦理委员会联系地址:

北京西城区永安路95号

Contact Address of the ethic committee:

95 Yongan Road, Xicheng District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

首都医科大学附属北京友谊医院

Primary sponsor:

Beijing Friendship Hospital, Capital Medical University

研究实施负责(组长)单位地址:

北京西城区永安路95号

Primary sponsor's address:

95 Yongan Road, Xicheng District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

西城区

Country:

China

Province:

Beijing

City:

Xicheng District

单位(医院):

首都医科大学附属北京友谊医院

具体地址:

西城区永安路95号

Institution
hospital:

Beijing Friendship Hospital, Capital Medical University

Address:

95 Yongan Road, Xicheng District

经费或物资来源:

自筹

Source(s) of funding:

Self-raised

研究疾病:

结直肠肿瘤  

Target disease:

colorectal neoplasia

研究疾病代码:

Target disease code:

研究类型:

诊断试验

Study type:

Diagnostic test

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

本研究采用多中心、前瞻性队列观察性研究设计,通过应用简便、有效的肠道清洁因素调查问卷,多因素分析发现肠道清洁的相关影响因素,根据其OR值赋予影响因素相应简化的系数,从而建立肠道清洁欠佳风险的预估评分模型,并在验证队列进行检验。该模型的建立有利于临床工作中对可能出现肠道清洁不良的人群进行提前干预,提高肠镜前肠道准备的效率,进一步提高结直肠癌早诊率,降低死亡率。  

Objectives of Study:

This multi-center, prospective cohort observational study aims to find risk factors of poor bowel cleansing by applying a simple and effective intestinal cleansing factor questionnaire. And the corresponding factors are given a simplified coefficient based on their OR, so as to establish an estimated scoring model of the risk of poor bowel cleansing and test it in the validation cohort. The establishment of this model is conducive to early intervention in clinical work for people who may have poor bowel cleansing, improve the efficiency of bowel preparation before colonoscopy, further increase the early diagnosis rate of colorectal cancer, and reduce mortality.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1)合并严重的心、脑血管、肝、肾、造血系统等原发性疾病者;
2)精神病患者和智力、语言障碍者;
3)妊娠或准备妊娠或哺乳期妇女;
4)患者3个月内参加了其他临床试验;
5)过敏体质及对本试验药有过敏者。
6)医生判断不适宜参加该项临床试验。

Exclusion criteria:

1) Patients with severe primary diseases with heart, cerebrovascular, liver, kidney, hematopoietic system;
2) Patients with mental illness and persons with intellectual or language impairments;
3) pregnant or preparing pregnant or lactating women;
4) Patients participated in other clinical trials within 3 months;
5) Allergies and those who are allergic to the test drug.
6) The doctor determines that it is not appropriate to participate in the clinical trial.

研究实施时间:

Study execute time:

From 2019-01-01 00:00:00 To 2021-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2019-01-01 00:00:00 To 2021-12-31 00:00:00

诊断试验:

Diagnostic Tests:

金标准或参考标准(即可准确诊断某疾病的单项方法或多项联合方法,在本研究中用于诊断是否有该病的临床参考标准):

临床结局

Gold Standard or Reference Standard (The clinical reference standards required to establish the presence or absence of the target condition in the tested population in present study):

Clinical outcomes

指标试验(即本研究的待评估诊断试验,无论为方法、生物标志物或设备,均请列出名称):

肠道清洁欠佳风险评分模型

Index test:

Risk assessment model for poor bowel cleansing

目标人群(可以是某种疾病患者或正常人群,详细描述其疾病特征,注意应纳入符合分布特点的全序列病例,具有良好的代表性)

具有结肠镜检查适应征,接受诊断性结肠镜的患者。

例数:

Sample size:

2100

Target condition (The target condition is a particular disease or disease stage that the index test will be intended to identify. Please specify the characteristics in detail; the population should has a complete spectrum and good representative):

Patients with colonoscopy indications who undergo diagnostic colonoscopy.

容易混淆的疾病人群(即与目标疾病不易区分的一种或多种不同疾病,应避免采用正常人群对照的病例-对照设计):

例数:

Sample size:

0

Population with condition difficult to distinguish from the target condition, the normal population in a case-control study design should be avoid:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

西城区 

Country:

China

Province:

Beijing

City:

Xicheng District

单位(医院):

首都医科大学附属北京友谊医院 

单位级别:

三级 

Institution
hospital:

Beijing Friendship Hospital, Capital Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

肠道清洁度

指标类型:

主要指标

Outcome:

Boston bowel preparation score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

SEN, SPE, ACC, AUC of ROC, PV+, PV-

指标类型:

主要指标

Outcome:

SEN, SPE, ACC, AUC of ROC, PV+, PV-

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

SEN, SPE, ACC, AUC of ROC, PV+, PV-

指标类型:

主要指标

Outcome:

SEN, SPE, ACC, AUC of ROC, PV+, PV-

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 90 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

不适用

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

未说明

Blinding:

Not stated

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

未说明 请阅读网页注册指南中关于“原始数据共享”的内容。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not stated

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

未说明 请阅读网页注册指南中关于 数据收集和管理系统 的内容。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Not stated

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-12-11 08:38:31